Cargando…
A Perspective on the Potential of Human iPS Cell-Based Therapies for Muscular Dystrophies: Advancements so far and Hurdles to Overcome
Autores principales: | Darabi, Radbod, Perlingeiro, Rita C.R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220265/ https://www.ncbi.nlm.nih.gov/pubmed/25383240 http://dx.doi.org/10.4172/2157-7633.1000e113 |
Ejemplares similares
-
iPSCs as a Platform for Disease Modeling, Drug Screening, and Personalized Therapy in Muscular Dystrophies
por: Ortiz-Vitali, Jose L., et al.
Publicado: (2019) -
An ex vivo Gene Therapy Approach to Treat Muscular Dystrophy Using inducible Pluripotent Stem Cells
por: Filareto, Antonio, et al.
Publicado: (2013) -
Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
por: Kazuki, Yasuhiro, et al.
Publicado: (2009) -
Generation and Characterization of a MYF5 Reporter Human iPS Cell Line Using CRISPR/Cas9 Mediated Homologous Recombination
por: Wu, Jianbo, et al.
Publicado: (2016) -
Development of allogeneic iPS cell‐based therapy: from bench to bedside
por: McKenna, David H, et al.
Publicado: (2022)